CRUSE Control Urticaria
CRUSE Control Urticaria is made and published by Moxie GmbH. AppBrain is an independent app data site and isn't affiliated with Moxie GmbH. The app name, icon, screenshots and description belong to Moxie GmbH and are shown as published on the App Store.
AppBrain's verdict
- Rating on App Store
- 4.75
- 8 ratings
- Last updated
- September 5, 2026
It doesn't have enough ratings yet to judge what users think.
Rankings
App Store top chartsApp Store Rankings for CRUSE Control Urticaria
Competitors
Similar apps and more from Moxie GmbH
Releases
Updates seen on the App Store- Version
- 1.0.115
- Launched
- July 2022
No changelog data
User feedback
Ratings and reviews on the App StoreComments on CRUSE Control Urticaria for iOS
We don't have enough comments to show example comments. Please check back later.
Technology
Found in the app by AppBrain- Price
- Free
- App size
- 35.2 MB
- Content rating
- High
Technologies used by CRUSE Control Urticaria
About the app and developer
About CRUSE Control Urticaria
CRUSE Control Urticaria is a medical app developed by Moxie GmbH.
User Ratings
CRUSE Control Urticaria is rated 4.75 out of 5 stars. The rating is based on 8 ratings.
App Information
CRUSE Control Urticaria is freely available from the App Store. The app size is 35.19 MB. The latest version available is 1.0.115. The last update was on September 5, 2026.
Technical Requirements
The app has a content rating of High Maturity. The app has been available on the App Store since July 2022.
Developer information for Moxie GmbH
Address:
Store listing
By Moxie GmbH, from the App Store
Description by Moxie GmbH Written by the developer, not by AppBrain. Click to read.
Take control of your Chronic Urticaria by recording your symptoms and impact on your quality of life in just a few minutes each day.
Track how you respond to treatment and how it can be improved by using CRUSE in cooperation with your treating physician.
Over 50 million people worldwide have Chronic Urticaria. It is a common condition that causes itchy wheals and/or swellings (angioedema) and can be very debilitating. To ensure optimal treatment, continuous monitoring and documentation of disease activity is essential. From now on, CRUSE® will take care of this for you.
Your UCARE Team - With more than 130 member centres in 41 countries, GA²LEN’s Urticaria Centres of Reference and Excellence (UCARE network) is the biggest and most active consortium of urticariologists and urticaria centres.
Are you a physician? Find out more on www.cruse-control-com